(Sharecast News) – Investors had a negative reaction to CLS Holdings’ half-year results on Wednesday, but that didn’t stop broker Berenberg keeping its ‘buy’ rating on the stock.
The office space company, which owns workspaces in the UK, Germany and France, reported a pre-tax loss of £106.4m for the six months ended 30 June, compared to a profit of £21.3m the year before, after taking a hit of £132.9m in valuation declines from its portfolio.

Nevertheless, the company reported a net rental income for the first half of £55.6m, up 5.3% year-on-year, as it maintained its interim dividend at 2.6p.

Berenberg highlighted that softening valuations in the UK (down 8.5% on a like-for-like basis) were somewhat offset by more resilient markets in Germany (-3.3%) and France (-1.9%), showing that the company’s “regional diversification is paying off”.

CLS’s recent investments have strengthened the quality of its portfolio, the broker says, after completing refurbishments of two office properties: Vauxhall Walk in London and Park Avenue in Lyon.

“As energy efficiency in both assets has materially improved, with the company now offering modern office space in good locations, we would expect CLS’s occupancy rates to pick up again over time, and the company’s leasing activities in the UK is also improving,” Berenberg wrote in a research note.

“CLS’s focus for the remainder of this year will be on improving its financial profile after already having made good progress on refinancing £178m of c£200m debt expiries in 2024.”

The broker kept its 175p price target unchanged, seeing upside beyond its current share price of 134.2p on Wednesday, down 6.4% on the day.

Shore Capital has reiterated its ‘buy’ stance on TP ICAP after the liquidity and data solutions specialist delivered a forecast-beating set of half-year results on Wednesday.

Underlying profits came in at £163m, up 15% year-on-year and ahead of Shore Capital’s £156m estimate, while the interim dividend of 4.8p was also higher than the 4.55p expected. Revenue, up 5% year-on-year at £1.13bn, was in line with forecasts.

The broker also highlighted the announcement of a £30m share buyback programme. “£100m of trapped capital has now been freed up six months ahead of schedule and will be used to pay down debt, with further opportunities to free-up cash being explored,” explained analyst Vivek Raja in a research note.

After an 11% fall in the share price so far this year, underperforming the FTSE All-Share Index by 12%, Shore Capital has retained its positive investment case on the stock with a prevailing fair value estimate of 200p.

“TCAP’s valuation remains modest on a 12-month forward PE of

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!